Corpus Intelligence IC Memo — COX MEDICAL CENTER BRANSON 2026-04-26 08:08 UTC
IC Memo — COX MEDICAL CENTER BRANSON
Investment Committee Memorandum | MO | 144 beds | Grade C | EBITDA uplift $16.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COX MEDICAL CENTER BRANSON

CCN 260094 | TANEY, MO | 144 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COX MEDICAL CENTER BRANSON is a 144-bed suburban community hospital in TANEY, MO with $217.3M in net patient revenue and a -0.8% operating margin. The hospital serves a payer mix of 25.4% Medicare, 11.6% Medicaid, and 63.0% commercial.

Thesis: Undervalued. Our ML models identify $16.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.8% to 6.6% (+736bps).

Net Revenue HCRIS$217.3M
Current EBITDA COMPUTED$-1.8M
Operating Margin COMPUTED-0.8%
Occupancy HCRIS49.8%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS24.1%
Distress Probability ML49.0%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
40
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -0.8% places it above the state median. Among 40 size-comparable peers (72-288 beds), the median margin is -2.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (72-288), prioritizing same-state peers. 40 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COX MEDICAL CENTER BRANSON (Target)MO144$217.3M-0.8%
SAINT FRANCIS MEDICAL CENTERMO282$556.6M-1.3%
UNIVERSITY HEALTH TRUMAN MED CMO258$540.8M-13.5%
AMEND 1 CENTERPOINT MEDICAL CEMO265$378.8M19.2%
BOONE HOSPITAL CENTERMO278$346.5M-22.5%
CHRISTIAN HOSPITAL NORTHEASTMO267$340.9M-6.6%
SOUTHEASTHEALTHMO232$335.2M-15.2%
ST. LUKES EAST - LEES SUMMITMO216$318.1M-5.8%
LIBERTY HOSPITALMO199$303.2M-3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.6M+210bp18mo
Cost to Collect4.5%2.5%$4.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.6M+122bp9mo
Clean Claim Rate88.0%96.0%$139K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.6M
Cost to Collect
$4.3M
Denial Rate Reduction
$4.3M
A/R Days Reduction
$2.6M
Clean Claim Rate
$139K
Total EBITDA Uplift$16.0M
Current EBITDA$-1.8M
+ RCM Uplift+$16.0M
Pro Forma EBITDA$14.2M
Current Margin-0.8%
Pro Forma Margin6.6%
WC Released (1x)$8.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.7M$148.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.7M$162.4M0.00x-100.0%
Bull Case9.0x11.0x$-2.4M$214.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.4M$233.1M0.00x-100.0%
Bear Case11.0x10.0x$-3.0M$69.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.0M$75.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 40 hospitals with 72-288 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-13.9% / P50=-2.9% / P75=8.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.